Previous studies reported axillary lymphadenopathy (LAP) as a side effect of the anti‐COVID‐19 vaccine. However, the effects of nonsteroidal anti‐inflammatory drug (NSAID)s on mRNA COVID‐19 vaccine‐related LAP have not been… Click to show full abstract
Previous studies reported axillary lymphadenopathy (LAP) as a side effect of the anti‐COVID‐19 vaccine. However, the effects of nonsteroidal anti‐inflammatory drug (NSAID)s on mRNA COVID‐19 vaccine‐related LAP have not been investigated.
               
Click one of the above tabs to view related content.